EVOK/ 11/04/2025 · 9:58 AM Evoke Pharma Shares Double Following Agreement to Be Acquired by QOL Medical for $11 Per Share QOL Medical buys Evoke Pharma for $11/share (140% premium). Evoke sells GIMOTI, a key nasal spray for diabetic stomach issues.